Cellular basis of drug‐induced torsades de pointes
- 1 August 2008
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 154 (7), 1502-1507
- https://doi.org/10.1038/bjp.2008.238
Abstract
Striking QT prolongation and the morphologically distinctive ventricular tachycardia torsades de pointes can occur in up to 5% of patients treated with certain antiarrhythmic drugs. This adverse drug reaction also occurs, albeit far less frequently, during therapy with a range of drugs not used for cardiovascular indications; examples include certain antibiotics, antipsychotics and antihistamines. The common mechanism for drug-induced torsades de pointes is inhibition of a specific repolarizing potassium current, I(Kr). The key question facing clinicians, regulators and those who develop drugs is why torsades de pointes only occurs in some patients exposed to I(Kr) block. This paper reviews the clinical, cellular, molecular and genetic features of the arrhythmia that may provide an answer to this question and proposes future studies in this area.This publication has 66 references indexed in Scilit:
- Mechanisms of Arsenic-Induced Prolongation of Cardiac RepolarizationMolecular Pharmacology, 2004
- Drug-Induced Prolongation of the QT IntervalThe New England Journal of Medicine, 2004
- Long QT syndrome caused by noncardiac drugsProgress in Cardiovascular Diseases, 2003
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionThe New England Journal of Medicine, 1999
- Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die?The American Journal of Cardiology, 1998
- Clinical safety profile of sotalol in patients with arrhythmiasThe American Journal of Cardiology, 1990
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- Quinidine-induced ventricular flutter and fibrillation without digitalis therapyThe American Journal of Cardiology, 1976
- Approaches to Sudden Death from Coronary Heart DiseaseCirculation, 1971
- Quinidine SyncopeCirculation, 1964